Article Details

Y-mAbs Therapeutics (NASDAQ:YMAB) Price Target Lowered to $68.00 at HC Wainwright

Retrieved on: 2021-06-28 11:35:45

Tags for this article:

Click the tags to see associated articles and topics

Y-mAbs Therapeutics (NASDAQ:YMAB) Price Target Lowered to $68.00 at HC Wainwright. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 2,418,580 shares of the company's stock worth $119,744,000 after acquiring an additional 72,823 shares in the last quarter.

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up